Drugs / AC VAX
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00801957 Background | Mar 2003 → Nov 2004 | atopic eczema | Astellas Pharma Inc | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AC VAX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00801957 ↗ |
| Modality | Vaccine | “a low dose of meningo polysaccharide vaccine” NCT00801957 ↗ |
| Route | Intramuscular | “im injection” NCT00801957 ↗ |